Показано 0 из 0
Дата |
---|
20:16 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
5.77
|
5.81
|
5.82
|
5.645
|
5.85
|
5.78
|
|
|
245 369.99
|
977.00
|
5.01
|
5.80
|
5.93
|
5.35
|
5.93
|
5.60
|
|
|
976 367.69
|
2 024.00
|
5.60
|
6.10
|
5.38
|
5.30
|
6.00
|
5.94
|
|
|
895 326.22
|
1 855.00
|
2.82
|
5.71
|
5.57
|
5.2416
|
5.57
|
5.32
|
|
|
499 074.62
|
2 485.00
|
5.50
|
7.55
|
5.38
|
5.335
|
5.905
|
5.61
|
|
|
501 459.26
|
1 341.00
|
2.19
|
5.80
|
5.3691
|
5.29
|
5.50
|
5.33
|
|
|
473 134.73
|
1 040.00
|
2.18
|
5.45
|
5.35
|
5.11
|
5.52
|
5.45
|
|
|
724 312.67
|
1 809.00
|
4.50
|
5.80
|
5.50
|
5.41
|
5.76
|
5.47
|
|
|
453 728.20
|
1 238.00
|
5.04
|
5.80
|
5.57
|
5.50
|
6.045
|
5.54
|
|
|
433 635.83
|
1 652.00
|
5.00
|
5.80
|
5.86
|
5.49
|
5.88
|
5.50
|
|
|
668 349.32
|
1 616.00
|
Monte Rosa Therapeutics, Inc. operates as a biotechnology company. The Company focuses on developing molecular glues to degrade disease-causing proteins. Monte Rosa Therapeutics serves customers in the United States and Switzerland.